Jennison Associates
SYNH

Jennison Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Jennison Associates’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-52,350
Closed -$4.58M – 742
2021
Q3 		$4.58M Sell
52,350
-247,022
-83% -$22.4M ﹤0.01% 490
2021
Q2 		$26.8M Sell
299,372
-174,846
-37% -$14.8M 0.02% 329
2021
Q1 		$36M Sell
474,218
-32,443
-6% -$2.45M 0.03% 262
2020
Q4 		$34.5M Sell
506,661
-26,007
-5% -$1.62M 0.02% 270
2020
Q3 		$28.3M Buy
532,668
+81,880
+18% +$4.88M 0.02% 266
2020
Q2 		$26.3M Sell
450,788
-5,011
-1% -$269K 0.02% 253
2020
Q1 		$18M Sell
455,799
-117,629
-21% -$6.88M 0.02% 271
2019
Q4 		$34.1M Buy
573,428
+280,734
+96% +$15.1M 0.03% 235
2019
Q3 		$15.6M Sell
292,694
-13,480
-4% -$692K 0.02% 344
2019
Q2 		$15.6M Sell
306,174
-11,532
-4% -$537K 0.02% 384
2019
Q1 		$16.4M Buy
317,706
+49,968
+19% +$2.42M 0.02% 386
2018
Q4 		$10.5M Buy
267,738
+1,622
+0.6% +$75.4K 0.01% 428
2018
Q3 		$13.7M Sell
266,116
-64,090
-19% -$3.14M 0.01% 442
2018
Q2 		$15.5M Sell
330,206
-301,014
-48% -$12.5M 0.02% 432
2018
Q1 		$22.4M Sell
631,220
-6,973
-1% -$273K 0.02% 382
2017
Q4 		$27.8M Sell
638,193
-283,925
-31% -$13.3M 0.03% 350
2017
Q3 		$48.2M Buy
922,118
+165,793
+22% +$9.24M 0.05% 278
2017
Q2 		$44.2M Sell
756,325
-111,352
-13% -$5.79M 0.05% 281
2017
Q1 		$39.8M Sell
867,677
-356,203
-29% -$17.7M 0.04% 309
2016
Q4 		$64.4M Buy
1,223,880
+227,069
+23% +$11M 0.07% 228
2016
Q3 		$44.4M Buy
996,811
+974,929
+4,455% +$42.3M 0.05% 293
2016
Q2 		$834K Buy
+21,882
New +$961K ﹤0.01% 574

Other funds holding SYNH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jennison Associates's SYNH Position: Q4 2021 in Review

Jennison Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 52,350 shares — an estimated $4.58M sold.

Jennison Associates first reported a position in SYNH in Q2 2016 and held it in 22 quarters. The position peaked at $64.4M in Q4 2016. 377 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

  • Jennison Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • Jennison Associates sold 52,350 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $4.58M.
  • Jennison Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 22 quarters.
  • Jennison Associates's Syneos Health, Inc. Class A Common Stock position peaked at $64.4M in Q4 2016.
  • 377 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Jennison Associates's 13F filing for Q4 2021, filed 8 Feb 2022.